Combined with cisplatin, it can affect the PI3K/AKT/mTOR signal transduction pathway, which leads to markedly increased cell apoptosis, indicating that rapamycin can mediate the sensitivity of pancreatic cancer cells to cisplatin [29]. Here, AKT1 is linked to pancreatic neoplasm.